The pharmaceutical dissolution testing services market is projected to grow from USD 813.0 million in 2025 to USD 1,804.5 million by 2035, at a CAGR of 8.3%. In Vitro will dominate with a 58.6% market share, while capsules will lead the dosage form segment with a 46.2% share.